Detalles de la búsqueda
1.
Evaluation of the drug-drug interaction potential of treosulfan using a physiologically-based pharmacokinetic modelling approach.
Br J Clin Pharmacol
; 88(4): 1722-1734, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34519068
2.
The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its synergistic interaction with the PARP-inhibitor olaparib.
Gynecol Oncol
; 159(3): 850-859, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32980128
3.
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium.
Biol Blood Marrow Transplant
; 24(8): 1651-1656, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753157
4.
Validation of a Commercial Assay and Decision Support Tool for Routine Paclitaxel Therapeutic Drug Monitoring (TDM).
Ther Drug Monit
; 39(6): 617-624, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28937535
5.
Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents.
Graefes Arch Clin Exp Ophthalmol
; 251(1): 279-84, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22782301
6.
Population pharmacokinetic modeling of treosulfan and rationale for dose recommendation in children treated for conditioning prior to allogeneic hematopoietic stem cell transplantation.
Drug Metab Pharmacokinet
; 52: 100515, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481830
7.
SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters.
Cancers (Basel)
; 15(11)2023 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37297005
8.
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
Biol Blood Marrow Transplant
; 17(3): 341-50, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20685259
9.
Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.
PLoS One
; 15(5): e0233739, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32437439
10.
Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells.
Mol Oncol
; 14(4): 686-703, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32037720
11.
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer.
Cell Death Discov
; 6: 12, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32194992
12.
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study.
Anticancer Drugs
; 20(2): 97-103, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19209025
13.
Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT).
Crit Rev Oncol Hematol
; 68(1): 66-90, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18439836
14.
Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
Cancer Chemother Pharmacol
; 62(1): 19-31, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17823799
15.
The 10th annual meeting of CESAR in Essen June 28 - 30, 2012, Germany.
Int J Clin Pharmacol Ther
; 51(1): 34, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23259993
16.
Variability in fluorouracil exposure during continuous intravenous infusion.
Int J Clin Pharmacol Ther
; 50(1): 82-4, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22192656
17.
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.
J Clin Oncol
; 23(5): 965-72, 2005 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-15613696
18.
Improved Treatment of MT-3 Breast Cancer and Brain Metastases in a Mouse Xenograft by LRP-Targeted Oxaliplatin Liposomes.
J Biomed Nanotechnol
; 12(1): 56-68, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27301172
19.
Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors, including colorectal cancer.
Clin Colorectal Cancer
; 5(3): 188-96, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16197622
20.
Assessing the contribution of the two protein disulfide isomerases PDIA1 and PDIA3 to cisplatin resistance.
J Inorg Biochem
; 153: 247-252, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26364260